TY - JOUR AU - Dougados, M. PY - 2016 DA - 2016// TI - Comorbidities in rheumatoid arthritis JO - Curr Opin Rheumatol VL - 28 UR - https://doi.org/10.1097/BOR.0000000000000267 DO - 10.1097/BOR.0000000000000267 ID - Dougados2016 ER - TY - JOUR AU - Mcinnes, I. B. AU - Schett, G. PY - 2011 DA - 2011// TI - The pathogenesis of rheumatoid arthritis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMra1004965 DO - 10.1056/NEJMra1004965 ID - Mcinnes2011 ER - TY - JOUR AU - Klareskog, L. AU - Padyukov, L. AU - Lorentzen, J. AU - Alfredsson, L. PY - 2006 DA - 2006// TI - Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis JO - Nature VL - 2 ID - Klareskog2006 ER - TY - STD TI - Sardar S, Andersson Å. Old and new therapeutics for rheumatoid arthritis: in vivo models and drug development. Immunopharmacol Immunotoxicol. 2016:1–12 https://doi.org/10.3109/08923973.2015.1125917. ID - ref4 ER - TY - JOUR AU - Gaffo, A. AU - Saag, K. AU - Curtis, J. PY - 2006 DA - 2006// TI - Treatment of rheumatoid arthritis JO - Am J Health-Syst Pharm VL - 63 UR - https://doi.org/10.2146/ajhp050514 DO - 10.2146/ajhp050514 ID - Gaffo2006 ER - TY - JOUR AU - Reynolds, A. AU - Koening, A. S. AU - Bananis, E. AU - Singh, A. PY - 2012 DA - 2012// TI - When is switching warranted among biologic therapies in rheumatoid arthritis? JO - Expert Rev Pharmacoecon Outcomes Res VL - 12 UR - https://doi.org/10.1586/erp.12.27 DO - 10.1586/erp.12.27 ID - Reynolds2012 ER - TY - JOUR AU - Yoshizaki, K. AU - Nishimoto, N. AU - Mihara, M. AU - Kishimoto, T. PY - 1998 DA - 1998// TI - Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody JO - Springer Semin Immunopathol VL - 20 UR - https://doi.org/10.1007/BF00832010 DO - 10.1007/BF00832010 ID - Yoshizaki1998 ER - TY - JOUR AU - Karsdal, M. A. AU - Schett, G. AU - Emery, P. PY - 2012 DA - 2012// TI - IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the Tocilizumab RADIATE study JO - Semin Arthritis Rheum VL - 42 UR - https://doi.org/10.1016/j.semarthrit.2012.01.004 DO - 10.1016/j.semarthrit.2012.01.004 ID - Karsdal2012 ER - TY - JOUR AU - Finzel, S. AU - Kraus, S. AU - Figueiredo, C. P. PY - 2019 DA - 2019// TI - Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis JO - Ann Rheum Dis VL - 6 UR - https://doi.org/10.1136/annrheumdis-2018-214894 DO - 10.1136/annrheumdis-2018-214894 ID - Finzel2019 ER - TY - JOUR AU - Sack, U. AU - Kinne, R. AU - Marx, T. AU - Heppt, P. AU - Bender, S. AU - Emmrich, F. PY - 1993 DA - 1993// TI - Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis JO - Rheumatol Int VL - 13 UR - https://doi.org/10.1007/BF00307733 DO - 10.1007/BF00307733 ID - Sack1993 ER - TY - JOUR AU - Madhok, R. AU - Crilly, A. AU - Watson, J. AU - Capell, H. A. AU - Royal, G. PY - 1993 DA - 1993// TI - Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity JO - Ann Rheum Dis VL - 52 UR - https://doi.org/10.1136/ard.52.3.232 DO - 10.1136/ard.52.3.232 ID - Madhok1993 ER - TY - JOUR AU - Kremer, J. M. AU - Blanco, R. AU - Brzosko, M. PY - 2011 DA - 2011// TI - Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30158 DO - 10.1002/art.30158 ID - Kremer2011 ER - TY - JOUR AU - Mcinnes, I. B. AU - Schett, G. PY - 2007 DA - 2007// TI - Cytokines in the pathogenesis of rheumatoid arthrits JO - Nat Rev Immunol VL - 7 UR - https://doi.org/10.1038/nri2094 DO - 10.1038/nri2094 ID - Mcinnes2007 ER - TY - JOUR AU - Karsdal, M. A. AU - Nielsen, M. J. AU - Sand, J. M. PY - 2013 DA - 2013// TI - Extracellular matrix remodeling: the common denominator in connective tissue diseases JO - Assay Drug Dev Technol VL - 11 UR - https://doi.org/10.1089/adt.2012.474 DO - 10.1089/adt.2012.474 ID - Karsdal2013 ER - TY - STD TI - Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3 https://doi.org/10.1101/cshperspect.a005058. ID - ref15 ER - TY - JOUR AU - Mohammed, F. F. AU - Smookler, D. S. AU - Khokha, R. PY - 2003 DA - 2003// TI - Metalloproteinases, inflammation, and rheumatoid arthritis JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.suppl_2.ii43 DO - 10.1136/ard.62.suppl_2.ii43 ID - Mohammed2003 ER - TY - JOUR AU - Burrage, P. S. AU - Mix, K. S. AU - Brinckerhoff, C. E. PY - 2006 DA - 2006// TI - Matrix metalloproteinases: role in arthritis JO - Front Biosci VL - 11 UR - https://doi.org/10.2741/1817 DO - 10.2741/1817 ID - Burrage2006 ER - TY - JOUR AU - Siebuhr, A. S. AU - Sun, S. AU - Byrjalsen, I. PY - 2018 DA - 2018// TI - Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis JO - Clin Exp Rheumatol VL - 36 ID - Siebuhr2018 ER - TY - JOUR AU - Karsdal, M. A. AU - Henriksen, K. AU - Leeming, D. J. PY - 2009 DA - 2009// TI - Biochemical markers and the FDA critical path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development JO - Biomarkers VL - 14 UR - https://doi.org/10.1080/13547500902777608 DO - 10.1080/13547500902777608 ID - Karsdal2009 ER - TY - JOUR AU - Bay-Jensen, A. C. AU - Platt, A. AU - Byrjalsen, I. AU - Vergnoud, P. AU - Christiansen, C. AU - Karsdal, M. A. PY - 2014 DA - 2014// TI - Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study JO - Semin Arthritis Rheum VL - 43 UR - https://doi.org/10.1016/j.semarthrit.2013.07.008 DO - 10.1016/j.semarthrit.2013.07.008 ID - Bay-Jensen2014 ER - TY - STD TI - Bay-Jensen AC, Platt A, Siebuhr AS, Christiansen C, Byrjalsen I, Karsdal MA. Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study. Arthritis Res Ther. 2016:7–15 https://doi.org/10.1186/s13075-015-0913-x. ID - ref21 ER - TY - JOUR AU - Siebuhr, A. S. AU - Bay-Jeensen, A. C. AU - Leeming, D. J. PY - 2013 DA - 2013// TI - Serological identification of fast progressors of structural damage with rheumatoid arthritis JO - Arthritis Res Ther VL - 15 UR - https://doi.org/10.1186/ar4266 DO - 10.1186/ar4266 ID - Siebuhr2013 ER - TY - JOUR AU - Gudmann, N. S. AU - Junker, P. AU - Juhl, P. PY - 2018 DA - 2018// TI - Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis JO - Clin Exp Rheumatol VL - 36 ID - Gudmann2018 ER - TY - JOUR AU - Kojima, T. AU - Yabe, Y. AU - Kaneko, A. AU - Hirano, Y. AU - Ishikawa, H. AU - Hayashi, M. PY - 2013 DA - 2013// TI - Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis JO - Mod Rheumatol VL - 23 UR - https://doi.org/10.3109/s10165-012-0782-y DO - 10.3109/s10165-012-0782-y ID - Kojima2013 ER - TY - JOUR AU - Juhl, P. AU - Thudium, C. S. AU - Gudmann, N. S. AU - Karsdal, M. A. AU - Siebuhr, A. S. PY - 2018 DA - 2018// TI - IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study JO - Clin Exp Rheumatol VL - 36 ID - Juhl2018 ER - TY - JOUR AU - Bay-jensen, A. AU - Byrjalsen, I. AU - Siebuhr, A. S. PY - 2014 DA - 2014// TI - Serological biomarkers of joint tissue turnover predict tocilizumab response at baseline JO - J Clin Rheumatol VL - 20 UR - https://doi.org/10.1097/RHU.0000000000000150 DO - 10.1097/RHU.0000000000000150 ID - Bay-jensen2014 ER - TY - JOUR AU - Jones, G. AU - Sebba, A. AU - Gu, J. PY - 2010 DA - 2010// TI - Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2008.105197 DO - 10.1136/ard.2008.105197 ID - Jones2010 ER - TY - STD TI - Leeming DJ, He Y, Veidal SS, et al. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 2011;16(7) https://doi.org/10.3109/1354750X.2011.620628. ID - ref28 ER - TY - JOUR AU - Bay-Jensen, A. C. AU - Liu, Q. AU - Byrjalsen, I. PY - 2011 DA - 2011// TI - Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM — increased serum CIIM in subjects with severe radiographic osteoarthritis JO - Clin Biochem VL - 44 UR - https://doi.org/10.1016/j.clinbiochem.2011.01.001 DO - 10.1016/j.clinbiochem.2011.01.001 ID - Bay-Jensen2011 ER - TY - JOUR AU - Barascuk, N. AU - Veidal, S. S. AU - Larsen, L. AU - Larsen, D. V. AU - Larsen, M. R. PY - 2010 DA - 2010// TI - A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen JO - Clin Biochem VL - 43 UR - https://doi.org/10.1016/j.clinbiochem.2010.03.012 DO - 10.1016/j.clinbiochem.2010.03.012 ID - Barascuk2010 ER - TY - STD TI - Karsdal MA, Genovese F, Madsen EA, Manon-Jensen T, Schuppan D. Collagen and tissue turnover as function of age: implications for fibrosis. J Hepatol. 2015;64(1) https://doi.org/10.1016/j.jhep.2015.08.014. ID - ref31 ER - TY - JOUR AU - Bay-Jensen, A. C. AU - Wichuk, S. AU - Byrjalsen, I. PY - 2013 DA - 2013// TI - Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0054504 DO - 10.1371/journal.pone.0054504 ID - Bay-Jensen2013 ER - TY - JOUR AU - Sokka, T. PY - 2008 DA - 2008// TI - Radiographic scoring in rheumatoid arthritis: a short introduction to the methods JO - Bull NYU Hosp Jt Dis VL - 66 ID - Sokka2008 ER -